Status:
COMPLETED
Investigating Cytokine Genes of Stem Cell Donors
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Stem Cell Transplantation
Eligibility:
All Genders
2-80 years
Brief Summary
This study seeks to investigate the factors that may account for the differences in the way a stem cell recipient s immune system works after a transplant. It will focus on cytokine genes, which give ...
Detailed Description
The NHLBI Stem Cell Allotransplantation Program is researching methods to improve allogeneic stem cell transplantation. We are particularly interested in identifying factors, which result in individua...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Participation as a stem cell donor on a Hematology Branch protocol.
- For adults: Ability to comprehend the investigational nature of the study and provide informed consent. For minors: Written informed consent from one parent or guardian. Informed assent from minors: The process will be explained to the minor on a level of complexity appropriate for their age and ability to comprehend.
- Age greater than or equal to 2 and less than or equal to 80.
- EXCLUSION CRITERIA:
- Subjects unable to comprehend the investigational nature of the laboratory research.
Exclusion
Key Trial Info
Start Date :
June 5 2003
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 2 2018
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT00353821
Start Date
June 5 2003
End Date
March 2 2018
Last Update
December 12 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States, 20892